We are live on ! Find out more
AF

Align Financial Portfolio holdings

AUM $202M
This Fund
S&P 500
This Quarter Est. Return
+13.68%
1 Year Est. Return
–
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$202M
AUM Growth
+$25.6M
Cap. Flow
+$1.92M
Cap. Flow %
0.95%
Top 10 Hldgs %
66.95%
Holding
376
New
3
Increased
24
Reduced
16
Closed
16
Avg Time Held
2 quarters
Top 10 Avg Time Held
1.7 quarters
Top 20 Avg Time Held
2 quarters

Sector Composition

Rank Sector Weight
1 Miscellaneous 89.36%
2 Technology 4.46%
3 Consumer Discretionary 1.37%
4 Financials 1.34%
5 Communication Services 1.27%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow Held Since
PFE icon
251
Pfizer
PFE
$161B
$12.4K 0.01%
514
– –
2025 Q4
2 quarters
JKHY icon
252
Jack Henry & Associates
JKHY
$10.5B
$11.8K 0.01%
86
– –
2025 Q4
2 quarters
VRSK icon
253
Verisk Analytics
VRSK
$23.1B
$11.7K 0.01%
65
– –
2025 Q4
2 quarters
ELV icon
254
Elevance Health
ELV
$89.5B
$11.6K 0.01%
30
– –
2025 Q4
2 quarters
KR icon
255
Kroger
KR
$36.4B
$11.1K 0.01%
200
– –
2025 Q4
2 quarters
PPL
256
PPL Corp
PPL
$25.8B
$10.7K 0.01%
294
– –
2025 Q4
2 quarters
COWZ icon
257
Pacer US Cash Cows 100 ETF
COWZ
$19.1B
$10.6K 0.01%
170
– –
2025 Q4
2 quarters
CLX icon
258
Clorox
CLX
$10.1B
$10.2K 0.01%
107
– –
2025 Q4
2 quarters
LMT icon
259
Lockheed Martin
LMT
$118B
$10.2K 0.01%
20
– –
2025 Q4
2 quarters
LSTR icon
260
Landstar System
LSTR
$5.74B
$10.1K 0.01%
49
– –
2025 Q4
2 quarters
IMFL icon
261
Invesco International Developed Dynamic Multifactor ETF
IMFL
$1.05B
$9.96K ﹤0.01%
290
– –
2025 Q4
2 quarters
BIO icon
262
Bio-Rad Laboratories Class A
BIO
$9.79B
$9.69K ﹤0.01%
33
– –
2025 Q4
2 quarters
TMO icon
263
Thermo Fisher Scientific
TMO
$243B
$9.53K ﹤0.01%
19
– –
2025 Q4
2 quarters
PTY icon
264
PIMCO Corporate & Income Opportunity Fund
PTY
$2.43B
$9.02K ﹤0.01%
750
-1,000
-57% -$12K
2025 Q4
2 quarters
TXN icon
265
Texas Instruments
TXN
$259B
$8.94K ﹤0.01%
30
– –
2025 Q4
2 quarters
AFL icon
266
Aflac
AFL
$57.4B
$8.79K ﹤0.01%
75
– –
2025 Q4
2 quarters
EFX icon
267
Equifax
EFX
$17.1B
$8.73K ﹤0.01%
55
– –
2025 Q4
2 quarters
CMCSA icon
268
Comcast
CMCSA
$73.3B
$8.69K ﹤0.01%
354
– –
2025 Q4
2 quarters
CG icon
269
Carlyle Group
CG
$13.7B
$8.51K ﹤0.01%
202
– –
2025 Q4
2 quarters
MELI icon
270
Mercado Libre
MELI
$95.8B
$8.49K ﹤0.01%
5
– –
2025 Q4
2 quarters
PSX icon
271
Phillips 66
PSX
$111B
$8.45K ﹤0.01%
50
– –
2025 Q4
2 quarters
WINA icon
272
Winmark
WINA
$1.05B
$7.62K ﹤0.01%
18
– –
2025 Q4
2 quarters
ADP icon
273
Automatic Data Processing
ADP
$107B
$7.61K ﹤0.01%
34
– –
2025 Q4
2 quarters
NDAQ icon
274
Nasdaq
NDAQ
$52.3B
$7.33K ﹤0.01%
93
– –
2025 Q4
2 quarters
SNPS icon
275
Synopsys
SNPS
$97.7B
$7.14K ﹤0.01%
16
– –
2025 Q4
2 quarters

Similar funds

Align Financial's Q2 2026 Portfolio in Review

As of Q2 2026, Align Financial held 376 positions worth $202M, up 15% from $176M the previous quarter. Its ten largest holdings account for 67% of the portfolio.

Align Financial's Q2 2026 filing shows 3 new, 24 increased, 16 reduced and 16 closed positions. Its largest new stake was Occidental Petroleum: 939 shares worth $45.6K. The largest sale was Vanguard Morningstar Total Stock Market ETF, an estimated $3.44M.

By sector, the portfolio is most concentrated in Miscellaneous at 89% of assets, down from 89% a quarter earlier, followed by Technology and Consumer Discretionary.

  • Align Financial's largest Q2 2026 buy was Occidental Petroleum: 939 shares worth $45.6K.
  • Align Financial added most to Avantis Core Fixed Income ETF in Q2 2026, an estimated $1.33M increase.
  • Align Financial's biggest Q2 2026 reduction was Vanguard Morningstar Total Stock Market ETF, cutting an estimated $3.44M.
  • Align Financial fully exited Schwab US Aggregate Bond ETF in Q2 2026, selling an estimated $73.8K.
  • Align Financial's ten largest holdings make up 67% of its $202M portfolio in Q2 2026.
  • Align Financial opened 3 new positions and closed 16 in Q2 2026.
  • Align Financial's portfolio value rose 15% quarter-over-quarter to $202M.

Based on Align Financial's 13F filing for Q2 2026, filed 27 Jul 2026.